Target intelligence / Profile preview

Serine Beta-Lactamase (N/A)

Target
N/A
Molecular classification
Enzyme, Hydrolase
01

Overview

Serine beta-lactamases are bacterial enzymes that hydrolyze beta-lactam antibiotics, conferring resistance. They belong to Ambler classes A, C, and D and utilize a conserved serine residue in their active site for catalysis. They are clinically relevant due to their role in antibiotic resistance and are targeted by beta-lactamase inhibitors.

Other names
Class A beta-lactamasesClass C beta-lactamasesClass D beta-lactamasesPenicillinasesCephalosporinasesOxacillinasesESBLs (extended-spectrum beta-lactamases)
02

Mechanism of action

Acylation-deacylation mechanism: nucleophilic attack on the beta-lactam ring by a serine residue, followed by hydrolysis of the acyl-enzyme intermediate.

03

Biological functions

Hydrolysis of beta-lactam antibioticsDrug resistance
04

Disease associations

InfectionAntibiotic resistance
05

Safety considerations

Development of resistance mutationsLimited efficacy of beta-lactam antibioticsTreatment failure in bacterial infections
06

Interacting drugs

Penicillins

4 more in the full profile.

Beyond the preview

Go deeper on Serine Beta-Lactamase (N/A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine Beta-Lactamase (N/A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call